Search

Search Constraints

You searched for: Author/Creator Hartrampf, Philipp E.

Search Results

2. Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy. Issue 14 (21st July 2022)

3. High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data. (10th March 2023)

4. Impact of 68Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors. (3rd January 2023)

5. Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4–Directed Molecular Imaging and Therapy. (22nd June 2023)

6. Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor–Directed Molecular Imaging and Therapy. (19th June 2022)

7. Long-term results of multimodal peptide receptor radionuclide therapy and fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma. (May 2020)

8. Peptide Receptor Radionuclide Therapy in Patients With Neurofibromatosis Type 2: Initial Experience. (June 2021)

9. Somatostatin Receptor-Directed PET/CT for Therapeutic Decision-Making and Disease Control in Patients Affected With Small Cell Lung Cancer. (8th April 2023)